Emergent BioSolutions Inc. (EBS) stock
EBSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3072% below fair value
$5.89−0.15 (-2.48%)
Close on Nov 12, 2026Market cap $302.00MP/E –Yield –
Emergent BioSolutions statistics
98 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 4.98
- 2.29
- P/OCF Ratio
- 1.51
- 12.93
Enterprise valuationIndustry
- EV / Sales
- 0.98
- 2.60
- EV / FCF
- 3.37
- 22.07
Share statisticsIndustry
- Shares Change (YoY)
- -2.75%
- 10.9%
- Shares Change (QoQ)
- 0.00%
- 0.48%
- Float
- 48M
- 49M
- Shares Held by Insiders
- 5.97%
- 12.1%
- Shares Held by Institutions
- 87.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 10M
- –
- Short Interest Change
- 4.09%
- -0.76%
- Short % of Float
- 20.9%
- 9.06%
- Short % of Shares Outstanding
- 19.7%
- 6.30%
- Days to Cover
- 10.07
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $14.06
- –
- 52-Week Low
- $4.36
- –
- 20-Day Moving Average
- $6.32
- –
- 50-Day Moving Average
- $6.51
- –
- 200-Day Moving Average
- $7.76
- –
- Average True Range (14)
- $0.42
- –
- Price Change (1 Week)
- 0.68%
- 1.51%
- Price Change (1 Month)
- -14.8%
- -2.37%
- Price Change (3 Months)
- 28.3%
- -21.1%
- Price Change (6 Months)
- -28.3%
- -22.8%
- Price Change (YTD)
- -52.3%
- -22.6%
- Price Change (1 Year)
- -45.9%
- -21.0%
- Price Change (3 Years)
- 223.6%
- -24.8%
- Price Change (5 Years)
- -84.1%
- -76.9%
- Price Change (10 Years)
- -80.9%
- -63.2%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.88
- 0.80
- Relative Strength Index (14)
- 39.9
- 44.7
- Volatility (1 Year)
- 69.1%
- 80.2%
- Beta (5 Years)
- 1.84
- 1.07
MarginsIndustry
- Pretax Margin
- -37.0%
- -11.8%
- EBITDA Margin
- -14.1%
- -27.7%
- FCF Margin
- 29.0%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- -58.2%
- -51.3%
- Return on Assets (ROA)
- -21.2%
- -40.7%
- Return on Invested Capital (ROIC)
- -17.3%
- -32.9%
- Return on Capital Employed (ROCE)
- -20.6%
- -38.1%
Financial positionIndustry
- Current Ratio
- 4.58
- 3.31
- Quick Ratio
- 2.08
- 2.41
- Debt / Equity
- 1.62
- 0.50
- Debt / FCF
- 2.69
- 4.68
- Interest Coverage
- -3.96
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- -17.7%
- 7.26%
- Net Income Growth (YoY)
- -443.5%
- -14.4%
- EPS Growth (YoY)
- -486.2%
- -11.7%
- FCF Growth (YoY)
- 13357.1%
- 7.48%
- Revenue Growth (3Y CAGR)
- -12.7%
- 2.25%
- Revenue Growth (5Y CAGR)
- -14.0%
- 6.41%
- EPS Growth (5Y CAGR)
- -30.4%
- 3.77%
EfficiencyIndustry
- Asset Turnover
- 0.53
- 0.40
- Inventory Turnover
- 1.05
- 2.73
- Revenue Per Employee
- $721.22K
- $429.38K
- Profits Per Employee
- -$289.67K
- -$683.67K
- Employee Count
- 900
- 75
- WACC
- 9.69%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- -$240.00M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- -$332.00M
- $16.98M
- Net Cash Per Share
- -$6.48
- $0.72
- Equity (Book Value)
- $313.20M
- $52.68M
- Book Value Per Share
- $6.11
- $1.50
- Tangible Book Value
- $60.70M
- $26.74M
- Working Capital
- $436.20M
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$11.70M
- -$944.00K
- FCF Per Share
- $3.67
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -86.3%
- -21.0%
- FCF Yield
- 62.4%
- -9.44%
- Buyback Yield
- 9.01%
- -0.73%
- Shareholder Yield
- 9.01%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $45.40M
- $2.97M
- Income Tax
- $20.70M
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- 0.33
- 0.26
- Piotroski F-Score
- 7
- 4
- Beneish M-Score
- -3.56
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | EBS | S&P 500 | Difference | EBS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -15.6% | -2.7% | −12.9 pts | ||
| 3 months | +29.5% | -1.7% | +31.2 pts | ||
| Year to date | -52.3% | +11.9% | −64.2 pts | ||
| 1 year | -45.5% | +12.0% | −57.5 pts | ||
| 3 years | +194.5% | +78.2% | +116.3 pts | +43.3% | +21.2% |
| 5 years | -84.1% | +73.2% | −157.3 pts | -30.7% | +11.6% |
| 10 years | -80.9% | +309.6% | −390.6 pts | -15.3% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
10M EBS shares were sold short on Oct 30, 2026, up 4.1% from the previous report, or 20.91% of the shares available to trade. At recent volumes it would take 10.1 days to buy them back. Over the last 20 sessions, 58.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 10,080,407 | +4.1% | 1,001,327 | 10.1 |
| Oct 15, 2026 | 9,684,744 | +4.2% | 1,073,649 | 9.0 |
| Sep 30, 2026 | 9,293,986 | -5.0% | 1,119,034 | 8.3 |
| Sep 15, 2026 | 9,786,380 | -9.7% | 1,138,009 | 8.6 |
| Aug 31, 2026 | 10,842,235 | -6.9% | 1,185,288 | 9.2 |
| Aug 14, 2026 | 11,640,558 | +16.1% | 1,940,233 | 6.0 |
| Jul 31, 2026 | 10,029,170 | -3.0% | 568,258 | 17.6 |
| Jul 15, 2026 | 10,339,037 | +0.7% | 785,751 | 13.2 |
| Jun 30, 2026 | 10,265,965 | +5.1% | 1,284,895 | 8.0 |
| Jun 15, 2026 | 9,772,053 | +0.1% | 761,981 | 12.8 |
| May 29, 2026 | 9,760,594 | +1.6% | 848,439 | 11.5 |
| May 15, 2026 | 9,604,080 | -1.8% | 800,704 | 12.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?